Study details
Enrolling now
Cardiac Power Output in Cardiogenic Shock Patients
University of Chicago
NCT IDNCT05700617ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
5
Study length
about 3 years
Ages
18+
Locations
1 site in IL
What this study is about
Researchers are testing whether differences in myocardial reserve can predict outcomes for heart failure patients. The trial is designed to assess the feasibility of using invasive hemodynamics of cardiac function, representing myocardial reserve, to predict clinical outcomes for heart failure patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 1:1 Randomization to receive milrinone
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
CARDIOVASCULAR SYSTEM
Endpoints
Primary: Death
Body systems
Cardiology / Heart